Inactive Instrument

News Vexim

Equities

ALVXM

FR0011072602

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

VEXIM: +17% Growth in Sales in 2017 up to €21.6 Million	18-01-12	BU
VEXIM : Announces the Results of the Simplified Tender Offer Initiated by Stryker	17-12-12	BU
NASS 2017: VEXIM Cancels the Investor & Analyst Lunch Meeting and Webcast Scheduled on Wednesday, October 25th	17-10-25	BU
VEXIM : to be Acquired by Stryker Corporation	17-10-24	BU
VEXIM: Strong First Half 2017 Results, in Line with Expectations	17-09-14	BU
VEXIM: Amendment of the Financial Agenda for 2017	17-09-13	BU
VEXIM: Continued Growth and Adoption of the SpineJack® in Q2 2017	17-07-11	BU
VEXIM: ANVISA Approves SpineJack® Implants in Brazil	17-05-29	BU
VEXIM : in Facts, Five Years after the Stock Market Listing on the Alternext Market	17-05-17	BU
Vexim : New Product Launch in Germany	17-05-03	PU
Vexim : Continued sales growth in Q1 2017	17-05-03	PU
VEXIM: Continued Sales Growth in Q1 2017	17-04-19	BU
VEXIM: New Product Launch in Germany: MASTERFLOW™ PLUS, a New Product Targeted at Low Energy Osteoporotic Fractures	17-04-18	BU
2016: A Historic Year for VEXIM	17-03-22	BU
VEXIM: Another Major Step Towards the SpineJack® Commercialization in the US	17-02-21	BU
VEXIM : strengthens its intellectual property protection for the SpineJack® in Asia	17-02-02	PU
VEXIM Strengthens Its Intellectual Property Protection for the SpineJack® in Asia: Two Patents Granted in China and Japan	17-02-02	BU
Vexim: Amendment of the Financial Agenda for 2017	17-01-30	BU
VEXIM : Strengthens its Management Team, Through the Appointment of Russell Powers as Vice President and General Manager for its US Business	17-01-19	BU
VEXIM : Sets New Sales Record in the 4th Quarter 2016 and Solidifies Its Position as a Major Player in Spine Trauma	17-01-17	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW